52North has been awarded funding from the National Institute for Health and Care Research (NIHR) to validate a community pathway for acute oncology patients, working with key hospital partners. Patients with acute oncology needs often have to travel to hospital for urgent assessments that, with the right technology, could take place closer to home. The grant will allow 52North to work with Dorset HealthCare University NHS Foundation Trust and Hertfordshire Community NHS Trust, alongside Macmillan Cancer Support and the UK Acute Oncology Society (UKAOS), to demonstrate how Neutrocheck® could change this at a system level.
52North awarded NIHR funding to validate a community pathway for acute oncology patients
